Cronos Group has received a number of expressions of interest about a possible sale and is reviewing those offers, the Toronto-based cannabis producer said.
“Cronos is in the initial stages of reviewing these indications of interest, and there can be no assurance that any agreement or transaction will result therefrom,” the company said in a news release.
ADVERTISEMENT
Reuters reported Thursday that Cronos is exploring a potential sale.
Cronos is currently working with a financial adviser to handle the expressions of interest from other companies, according to the news agency.
Reuters said U.S.-based multistate operator Curaleaf Holdings was among those parties.
Curaleaf, headquartered in Wakefield, Massachusetts, said in a statement that it will “… refrain from commenting on market rumors. The Company does not intend to make further comment unless required by law.”
Virginia-based Altria Group, one of the world’s largest tobacco producers, owns 41% of Cronos’ shares.
Read full article on Marijuana Business Daily
